NCT05270109

Brief Summary

Tonsillectomy, with or without adenoidectomy, in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number is increasing. Alone in Denmark, approximately 8.000 tonsillectomies are performed annually. Although, tonsillectomy on benign indication is considered to be a minor and frequently performed surgical procedure, the operation is associated with significant morbidity. Postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent, and PTH is potentially life threatening. In cold steel tonsillectomy, the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. This method has been used for the past 50 years, and is considered the "Gold Standard". However, new so-called "hot techniques have been developed. One of these is an impedance-dependent tissue sealer device (BiZactTM). The equipment used for BiZactTM tonsillectomy is EC certificated (CE nr. 00500). The equipment is commonly used for tonsillectomy both internationally and in Denmark, and preliminary results in both adults and children are promising. However, when a gold standard technique is replaced by a new technique, it is recommended that the decision is based on evidence obtained in randomized controlled designs, and preferably as a multicenter study. Within the scope of the CE marking of the equipment, the purpose of the present study is to conduct a randomized controlled trial (RCT) in order to investigate whether tonsillectomy performed with BiZactTM "hot" technique is beneficial or at least non-inferior compared to the gold standard cold steel technique in terms of affecting the incidence of post-tonsillectomy morbidity, interoperative factors, patient satisfaction, and health related quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 8, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2025

Completed
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

2.2 years

First QC Date

February 15, 2022

Last Update Submit

February 13, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of PTH

    • Incidence of PTH defined as haemorrhage requiring haemostasis with; bipolar electric coagulation, ligature, compression and/or medical treatment with antifibrinolyticum within the first 24 hours after surgery until 30 days after surgery.

    24 hours until 30 days after surgery

  • Postoperative pain

    • Postoperative pain assessed on a 11point numeric rating scale ranging from 0 "no pain" to 10 "worst possible pain". The Wong-Baker Faces rating scale is used for children.

    From the day of surgery until 14 days after the surgery

Secondary Outcomes (6)

  • Blood loss

    Intraoperative

  • Knife time

    First day of surgery

  • PROM

    From the day of the surgery until 6 months after the surgery

  • Unscheduled contacts to the health care system

    From the day of the surgery until 14 days after

  • Health related quality of life

    From the day of the surgery until 6 months after the surgery

  • +1 more secondary outcomes

Study Arms (2)

BiZact

EXPERIMENTAL
Procedure: BiZact

Cold Steel

ACTIVE COMPARATOR
Procedure: Cold Steel

Interventions

BiZactPROCEDURE

In the "hot group" the peritonsillar space is dissected and sealed in one step by a bipolar instrument (BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is automatically adjusted and delivered to the tissue in order minimize thermal tissue damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue.

BiZact
Cold SteelPROCEDURE

In the "cold steel group" the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery.

Cold Steel

Eligibility Criteria

Age4 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Obstruction/ tonsillar hypertrophy.
  • Recurrent tonsillitis, including previous peritonsillar abscess
  • Chronic tonsillitis
  • Systemic complications to tonsillitis (glomerulonephritis)
  • Other (Mononucleosis), PFAPA (Periodic Fever, Aphtous stomatitis, pharyngitis, cervical adenitis)
  • Foetor ex ore (tonsillar plugs)
  • Peritonsillar abscess (Tonsillectomy a chaud)
  • Ability to understand the written patient information and to give informed consent

You may not qualify if:

  • Diseases in the hematopoietic system
  • Antithrombotic or anticoagulant drugs in the recovery period
  • Suspicion of/known tonsillar malignancies or other malignancy
  • Patients or caregivers unable to read or speak Danish
  • Patients or caregivers unable to use online application for self-evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Line Schiøtt Nissen

Gødstrup, 7400, Denmark

Location

Related Publications (2)

  • Molhave M, Lyhne NM, Jensen DF, Nielsen SH, Hahn P, Holm JK, Ovesen T, Bertelsen J. BiZact versus cold steel for post-tonsillectomy hemorrhage: a multicenter randomized trial. Eur Arch Otorhinolaryngol. 2025 Dec;282(12):6449-6457. doi: 10.1007/s00405-025-09703-3. Epub 2025 Oct 13.

  • Nissen LS, Bertelsen J, Lyhne NM, Nielsen SH, Hahn P, Holm J, Ovesen T. Cold steel versus impedance-dependent tissue sealer tonsillectomy - a study protocol for a randomised controlled trial. Dan Med J. 2023 Nov 23;70(12):A06230366.

Study Officials

  • Line S Nissen, MD

    Regional Hospital West Jutland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 15, 2022

First Posted

March 8, 2022

Study Start

May 1, 2022

Primary Completion

July 25, 2024

Study Completion

January 21, 2025

Last Updated

February 17, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations